PEDIATRICS Vol. 88 No. 4 October 1991, pp. 828-833
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seidman, D. S.
Right arrow Articles by Gale, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seidman, D. S.
Right arrow Articles by Gale, R.

Neonatal Hyperbilirubinemia and Physical and Cognitive Performance at 17 Years of Age

Daniel S. Seidman MD1, Ido Paz BMSc2, David K. Stevenson MD3, Arie Laor MD, MSc4, Yehuda L. Danon MD5, and Rena Gale MD2

1 From the Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel
2 From the Department of Neonatology, Bikur Cholim Hospital, Jerusalem, Israel
3 From the Department of Pediatrics, Stanford University School of Medicine, Stanford, California
4 From the Medical Statistics Branch, Israel Defence Forces Corps
5 From the Division of Pediatric Immunology, Beleinson Medical Center, Sackler School of Medicine, Tel-Aviv University, Israel; the Medical Statistics Branch, Israel Defence Forces Corps

To estimate the effect of neonatal hyperbilirubinemia on long-term cognitive ability in full-term newborns with a negative Coombs test, we performed a 17-year historical prospective study of 1948 subjects. Intelligence tests and medical examinations performed at the military draft board were stratified according to serum bilirubin concentration. A logistic regression analysis was used to adjust for the confounding effects of gestational age, birth weight, Apgar score, ethnic origin, socioeconomic class, paternal education, birth order, and the administration of phototherapy and exchange transfusion. No direct linear association was shown between neonatal bilirubin levels and intelligence test scores or school achievement at 17 years of age. However, the risk for low intelligence test scores (IQ score <85) was found to be significantly higher (P = .014) among full-term male subjects with serum bilirubin levels above 342 µmol/L (20 mg/dL) (odds ratio, 2.96; 95% confidence interval, 1.29-6.79). This association was not observed among female subjects. We conclude that severe neonatal hyperbilirubinemia, among full-term male newborns with a negative Coombs test, could be associated with lower IQ scores at 17 years of age.

Key Words: neonatal hyperbilirubinemia • jaundice • long-term outcome • cognitive performance • intelligence test scores

Submitted on October 15, 1990
Accepted on January 28, 1991




This article has been cited by other articles:


Home page
NEJMHome page
T. B. Newman, P. Liljestrand, R. J. Jeremy, D. M. Ferriero, Y. W. Wu, E. S. Hudes, G. J. Escobar, and the Jaundice and Infant Feeding Study Team
Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more.
N. Engl. J. Med., May 4, 2006; 354(18): 1889 - 1900.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
W.-X. Chen and V. Wong
Visual Evoked Potentials in Neonatal Hyperbilirubinemia
J Child Neurol, January 1, 2006; 21(1): 58 - 62.
[Abstract] [PDF]


Home page
PediatricsHome page
L. A. Croen, C. K. Yoshida, R. Odouli, and T. B. Newman
Neonatal Hyperbilirubinemia and Risk of Autism Spectrum Disorders
Pediatrics, February 1, 2005; 115(2): e135 - e138.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
Follow-up Care of High-Risk Infants
Pediatrics, November 1, 2004; 114(5/S1): 1377 - 1397.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
Subcommittee on Hyperbilirubinemia
Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation
Pediatrics, July 1, 2004; 114(1): 297 - 316.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
S. Ip, M. Chung, J. Kulig, R. O'Brien, R. Sege, S. Glicken, M. J. Maisels, J. Lau, and Subcommittee on Hyperbilirubinemia
An Evidence-Based Review of Important Issues Concerning Neonatal Hyperbilirubinemia
Pediatrics, July 1, 2004; 114(1): e130 - e153.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
L. R. Atkinson, G. J. Escobar, J. I. Takayama, and T. B. Newman
Phototherapy Use in Jaundiced Newborns in a Large Managed Care Organization: Do Clinicians Adhere to the Guideline?
Pediatrics, May 1, 2003; 111(5): e555 - 561.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
Y. Yilmaz, S. Degirmenci, F. Akdas, S. Kulekci, A. Ciprut, S. Yuksel, F. Yildiz, L. Karadeniz, and A. Say
Prognostic Value of Auditory Brainstem Response for Neurologic Outcome in Patients With Neonatal Indirect Hyperbilirubinemia
J Child Neurol, October 1, 2001; 16(10): 772 - 775.
[Abstract] [PDF]


Home page
NEJMHome page
P. A. Dennery, D. S. Seidman, and D. K. Stevenson
Neonatal Hyperbilirubinemia
N. Engl. J. Med., February 22, 2001; 344(8): 581 - 590.
[Full Text] [PDF]


Home page
BMJHome page
H. T. Sørensen, K. J Rothman, M. W Gillman, F. H. Steffensen, P. Fischer, and S. Sabroe
Historical cohort study of in utero exposure to uterotonic drugs and cognitive function in young adult life
BMJ, February 13, 1999; 318(7181): 433 - 434.
[Full Text]


Home page
Clin. Chem.Home page
P. Rosenthal
Assessing liver function and hyperbilirubinemia in the newborn
Clin. Chem., January 1, 1997; 43(1): 228 - 234.
[Abstract] [Full Text] [PDF]